Tarsons Products Ltd Hits Intraday High with 7.07% Surge on 3 Feb 2026

2 hours ago
share
Share Via
Tarsons Products Ltd demonstrated robust intraday strength on 3 Feb 2026, surging to an intraday high of Rs 210.45, marking a 9.81% rise from its previous close. The stock outperformed its sector and the broader market, reflecting notable trading momentum in the healthcare services segment.
Tarsons Products Ltd Hits Intraday High with 7.07% Surge on 3 Feb 2026

Intraday Trading Highlights

On 3 Feb 2026, Tarsons Products Ltd opened with a gap-up gain of 3.84%, signalling strong buying interest from the outset. The stock continued to build on this momentum, reaching a peak price of Rs 210.45 during the session, representing a 9.81% increase from the prior day’s close. By the end of the trading day, the stock recorded a gain of 7.07%, significantly outperforming the Sensex, which rose by 2.62% on the same day.

The stock’s performance also surpassed the Plastic Products sector’s gain of 2.1%, with Tarsons outpacing the sector by 3.87%. This relative strength highlights the stock’s distinct trading action amid broader market movements.

Technical Positioning and Moving Averages

From a technical perspective, Tarsons Products Ltd’s price currently trades above its 5-day moving average, indicating short-term positive momentum. However, it remains below its 20-day, 50-day, 100-day, and 200-day moving averages, suggesting that the stock is still navigating resistance levels on a medium to long-term basis. This positioning reflects a stock in recovery mode, with recent gains not yet fully reversing prior downtrends.

Sector and Market Context

The healthcare services sector, to which Tarsons belongs, has seen mixed activity, but the Plastic Products segment, closely related to the company’s operations, gained 2.1% on the day. This sectoral gain was modest compared to Tarsons’ intraday surge, underscoring the stock’s standout performance.

Meanwhile, the broader market displayed volatility. The Sensex opened sharply higher by 3,656.74 points but lost momentum, retreating by 1,618.84 points to close at 83,704.36, a net gain of 2.5%. The index remains 2.93% below its 52-week high of 86,159.02. Notably, the Sensex is trading below its 50-day moving average, although the 50-day average itself is positioned above the 200-day average, indicating a mixed technical backdrop for the market.

Rising fast and still accelerating! This Small Cap from FMCG sector is riding pure momentum right now. Jump in before the rally reaches its peak!

  • - Accelerating price action
  • - Pure momentum play
  • - Pre-peak entry opportunity

Jump In Before It Peaks →

Performance Metrics Over Various Timeframes

While Tarsons Products Ltd exhibited strong gains today, its longer-term performance remains subdued relative to the broader market. Over the past week, the stock gained 4.37%, outperforming the Sensex’s 2.38% rise. However, over the last month, the stock declined by 12.66%, compared to a 2.28% drop in the Sensex. The three-month performance shows a sharper decline of 28.99%, while the Sensex remained nearly flat with a 0.21% loss.

Year-to-date, Tarsons is down 12.04%, lagging the Sensex’s 1.66% decline. Over the past year, the stock has fallen 45.27%, contrasting with the Sensex’s 8.57% gain. The three-year performance is notably weak, with a 70.67% drop, while the Sensex appreciated by 37.74%. The stock’s five- and ten-year returns stand at zero, reflecting a lack of appreciation over these longer horizons, whereas the Sensex has delivered 66.75% and 245.96% gains respectively.

Mojo Score and Grade Update

Tarsons Products Ltd holds a Mojo Score of 31.0, categorised under a Sell grade as of 1 Feb 2026, an improvement from its previous Strong Sell rating. The Market Cap Grade is rated 3, indicating a moderate market capitalisation relative to peers. These ratings provide a quantitative assessment of the stock’s current standing within the healthcare services sector.

Trading Activity and Market Capitalisation

The stock’s market capitalisation and trading volumes have supported its recent price action. The gap-up opening and sustained intraday gains reflect active participation from market participants. Despite the broader market’s mixed session, Tarsons Products Ltd’s share price demonstrated resilience and relative strength, contributing to its outperformance within the healthcare services industry.

Tarsons Products Ltd or something better? Our SwitchER feature analyzes this small-cap Healthcare Services stock and recommends superior alternatives based on fundamentals, momentum, and value!

  • - SwitchER analysis complete
  • - Superior alternatives found
  • - Multi-parameter evaluation

See Smarter Alternatives →

Summary of Market Conditions

The broader market environment on 3 Feb 2026 was characterised by initial optimism followed by profit-taking, as evidenced by the Sensex’s volatile session. Mega-cap stocks led the market gains, supporting a 2.5% rise in the Sensex despite the intraday pullback. Tarsons Products Ltd’s strong intraday performance stands out against this backdrop, highlighting its distinct trading dynamics within the healthcare services sector.

While the stock’s price remains below several key moving averages, the short-term momentum and intraday gains suggest active repositioning by traders. The healthcare services sector’s mixed performance contrasts with Tarsons’ notable outperformance, underscoring the stock’s unique market behaviour on the day.

Conclusion

Tarsons Products Ltd’s intraday high of Rs 210.45 and a 7.07% day gain on 3 Feb 2026 reflect a strong trading session marked by a gap-up opening and sustained buying interest. The stock outperformed both its sector and the broader market, despite a volatile Sensex session. Technical indicators show short-term strength, though longer-term moving averages remain resistance points. The stock’s performance metrics over various timeframes indicate challenges in maintaining gains beyond the immediate session, but today’s price action highlights a significant moment of market focus on Tarsons Products Ltd within the healthcare services industry.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News